Canntab Therapeutics Limited
Canntab Therapeutics Limited
CSE Index:
Currency:
Canntab Therapeutics Limited is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. Canntab has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. Simply put, Canntab's mission is to put the "Medical" into medicinal cannabis.
Canntab Therapeutics Limited (PILL)
SEDAR Information
Company Info
Address
1 Adelaide St. East, Suite 801
Toronto, ON M5C 2V9
CanadaPhone
(647) 209-3279Email
[email protected]Website
https://canntab.caListing date
Thursday, April 21, 2011Transfer Agent
Capital Transfer AgencyCapitalization
Issued & Outstanding:
38909159Reserved for Issuance:
16510036News Releases
22/11/2022
CANNTAB ANNOUNCES CORPORATE UPDATE
Bulletins
14/06/2024
2024-0613 - Delist - Canntab Therapeutics Limited (PILL)
le 14 juin/June 2024
The common shares of Canntab Therapeutics Limited will be delisted from the CSE at market close today, June 14, 2024.
Canntab Therapeutics is currently suspended. See bulletin 2023-1008.
___________________________
